{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:11:30Z","timestamp":1774293090638,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Bank"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10561-020-09810-x","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T21:03:45Z","timestamp":1581541425000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serological testing for infectious diseases markers of donor specimens from 24\u00a0h after death show no significant change in outcomes from other specimens"],"prefix":"10.1007","volume":"21","author":[{"given":"Chee Choy","family":"Kok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidiya","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"Egilmezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghamitra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0988-7827","authenticated-orcid":false,"given":"William D.","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"9810_CR1","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1128\/jcm.02447-10","volume":"49","author":"C Baleriola","year":"2011","unstructured":"Baleriola C, Johal H, Jacka B, Chaverot S, Bowden S, Lacey S, Rawlinson W (2011) Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at \u2212\u200920\u00b0C and \u2212\u200970\u00b0C. J Clin Microbiol 49:3163\u20133167. https:\/\/doi.org\/10.1128\/jcm.02447-10","journal-title":"J Clin Microbiol"},{"key":"9810_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10561-011-9252-6","volume":"13","author":"C Baleriola","year":"2012","unstructured":"Baleriola C, Johal H, Robertson P, Jacka B, Whybin R, Taylor P, Rawlinson WD (2012) Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens. Cell Tissue Bank 13:251\u2013258. https:\/\/doi.org\/10.1007\/s10561-011-9252-6","journal-title":"Cell Tissue Bank"},{"key":"9810_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1423-0410.2008.01104.x","volume":"95","author":"LJ Brant","year":"2008","unstructured":"Brant LJ, Davison KL (2008) Infections detected in English surgical bone and deceased donors (2001\u20132006) and estimated risk of undetected hepatitis B and hepatitis C virus. Vox Sang 95:272\u2013279","journal-title":"Vox Sang"},{"key":"9810_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1086\/314000","volume":"31","author":"FL Delmonico","year":"2000","unstructured":"Delmonico FL (2000) Cadaver donor screening for infectious agents in solid organ transplantation. Clin Infect Dis 31:781\u2013786","journal-title":"Clin Infect Dis"},{"key":"9810_CR5","volume-title":"Guidance for industry: Recommendations for obtaining a labeling claim for communicable disease donor screening tests using cadaveric blood specimens from donors of human cells, tissues and cellular and tissue-based products (HCT\/Ps)","author":"FDA","year":"2004","unstructured":"FDA (2004) Guidance for industry: Recommendations for obtaining a labeling claim for communicable disease donor screening tests using cadaveric blood specimens from donors of human cells, tissues and cellular and tissue-based products (HCT\/Ps). United States Department of Health and Human Services, Washington"},{"key":"9810_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<291::AID-JMV16>3.0.CO;2-D","volume":"58","author":"A Heim","year":"1999","unstructured":"Heim A, Wagner D, Rothamel T, Hartmann U, Flik J, Verhagen W (1999) Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation. J Med Virol 58:291\u2013295","journal-title":"J Med Virol"},{"key":"9810_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.ackd.2009.05.002","volume":"16","author":"MG Ison","year":"2009","unstructured":"Ison MG (2009) The epidemiology and prevention of donor-derived infections. Adv Chronic Kidney Dis 16:234\u2013241. https:\/\/doi.org\/10.1053\/j.ackd.2009.05.002","journal-title":"Adv Chronic Kidney Dis"},{"key":"9810_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s10561-012-9358-5","volume":"14","author":"AD Kitchen","year":"2013","unstructured":"Kitchen AD, Newham JA, Gillan HL (2013) Effective serological and molecular screening of deceased tissue donors. Cell Tissue Bank 14:633\u2013644. https:\/\/doi.org\/10.1007\/s10561-012-9358-5","journal-title":"Cell Tissue Bank"},{"key":"9810_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/jmv.2183","volume":"66","author":"M Miedouge","year":"2002","unstructured":"Miedouge M et al (2002) Screening of blood from potential organ and cornea donors for viruses. J Med Virol 66:571\u2013575","journal-title":"J Med Virol"},{"key":"9810_CR10","volume-title":"Australian code of good manufacturing practice\u2014human blood and tissues; section\u00a0827","author":"TGA","year":"2000","unstructured":"TGA (2000) Australian code of good manufacturing practice\u2014human blood and tissues; section\u00a0827. TGA, Canberra"},{"key":"9810_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00007890-199703150-00026","volume":"63","author":"DP Turner","year":"1997","unstructured":"Turner DP, Zuckerman M, Alexander GJ, Waite J, Wreghitt T (1997) Risk of inappropriate exclusion of organ donors by introduction of hepatitis B core antibody testing. Transplantation 63:775\u2013777","journal-title":"Transplantation"},{"key":"9810_CR12","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1111\/j.1600-6143.2007.02012.x","volume":"7","author":"F Yao","year":"2007","unstructured":"Yao F, Seed C, Farrugia A, Morgan D, Cordner S, Wood D, Zheng MH (2007) The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia. Am J Transplant 7:2723\u20132726. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.02012.x","journal-title":"Am J Transplant"},{"key":"9810_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/j.1432-2277.2008.00703.x","volume":"21","author":"F Yao","year":"2008","unstructured":"Yao F, Seed C, Farrugia A, Morgan D, Wood D, Zheng MH (2008) Comparison of the risk of viral infection between the living and nonliving musculoskeletal tissue donors in Australia. Transpl Int 21:936\u2013941. https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00703.x","journal-title":"Transpl Int"}],"container-title":["Cell and Tissue Banking"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10561-020-09810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10561-020-09810-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10561-020-09810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T14:36:27Z","timestamp":1613054187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10561-020-09810-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9810"],"URL":"https:\/\/doi.org\/10.1007\/s10561-020-09810-x","relation":{},"ISSN":["1389-9333","1573-6814"],"issn-type":[{"value":"1389-9333","type":"print"},{"value":"1573-6814","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"4 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no funding sources or conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal rights"}},{"value":"Ethical approval for this project was assessed by the LNR Committee in accordance with the \u201cNew South Wales Health Guideline GL2007_020 Human Research Ethics Committees\u2014Quality Improvement and Ethics Review: A Practice Guide for New South Wales\u201d and was recommended to be a quality improvement or quality assurance (QA\/QI) activity not requiring independent ethics review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"No informed consent was required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}